NCT05239520

Brief Summary

The aim of this study is to identify factors for shoulder instability in people with Facioscapulohumeral dystrophy (FSHD). FSHD is a non-life limiting condition with symptoms presenting in the second decade of life (Evangelista et al., 2016). Between 2500 to 3000 people are diagnosed with FSHD in the UK and it is the third most common dystrophy. The overall prevalence is 1: 20,000 and on average 52 people are newly diagnosed with FSHD each year (Emery, 1991; Padberg et al., 1995; UK, 2020) As the disease progresses, patients lose the ability to adequately control muscles around the shoulder girdle, possibly contributing to the development of shoulder instability i.e. partial or complete dislocation of the shoulder joint (Bergsma, Cup, Geurts, \& De Groot, 2015; Bergsma, Cup, Janssen, Geurts, \& de Groot, 2017; Mul et al., 2016). Loss of control around the shoulder is also thought to contribute to pain and a reduced capacity to perform tasks above shoulder height. Additionally, the development of fatigue and chronic pain further limit patient's abilities and engagement with rehabilitation. If we better understand the mechanisms associated with instability, we can better target physiotherapy interventions to improve rehabilitation. If we identify specific patterns of activity associated with instability, these could be addressed through personalised and improved exercise prescription and rehabilitation. Additionally, we may identify causes of instability for which physiotherapy or exercise programmes may not be appropriate, therefore ensuring patients are referred to the correct service in a timely manner, improving patient outcomes and allocating resources more appropriately.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
14

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Mar 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 27, 2022

Completed
19 days until next milestone

First Posted

Study publicly available on registry

February 15, 2022

Completed
1 month until next milestone

Study Start

First participant enrolled

March 25, 2022

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 21, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 21, 2022

Completed
Last Updated

February 1, 2023

Status Verified

January 1, 2023

Enrollment Period

7 months

First QC Date

January 27, 2022

Last Update Submit

January 31, 2023

Conditions

Keywords

BiomechanicsHuman movement analysisElectromyographyUltrasound

Outcome Measures

Primary Outcomes (5)

  • Kinematic features of movement: joint angles (degrees)

    Range of movement values and associated derivatives will be reported for the associated movement tasks.

    Day 1

  • Kinematic features of movement: displacement (mm)

    Displacement values and associated derivatives will be reported for associated movement tasks.

    Day 1

  • Kinetic variables related to the movement tasks: Force (Nm)

    Force values for the strength testing, joint contact and muscle force values will be reported for associated movement tasks.

    Day 1

  • Muscle activity patterns related to the movement tasks: Surface electromyography (mv)

    Muscle activity patterns related to the movement tasks will be reported for associated movement tasks.

    Day 1

  • Ultrasound imaging: Muscle architecture parameters (mm)

    Muscle architecture parameters where possible (Muscle thickness)

    Day 1

Study Arms (2)

People affected by FSHD

Participants with a diagnosis of FSHD. 3D movement analysis session including surface electromyography and Ultrasound.

Other: 3D movement analysis with surface electromyography and ultrasound

Age matched control group

Participants without a diagnosis of FSHD. 3D movement analysis session including surface electromyography and Ultrasound

Other: 3D movement analysis with surface electromyography and ultrasound

Interventions

Single measurement session of 3D movement analysis with surface electromyography for upper limb movements and ultrasound measurements of upper muscles

Age matched control groupPeople affected by FSHD

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

This study will consist of people aged 18 years of age and older. The two groups will include people with (people affected by FSHD) and without FSHD (age matched controls).

You may qualify if:

  • Stratified groups
  • Able to lift arms above shoulder height (n=3)
  • Unable to lift arms above shoulder height (n=2)
  • Post Scapulothoracic shoulder arthrodesis (n=2)
  • Diagnosed with FSHD
  • Aged 18 years and older

You may not qualify if:

  • Recent trauma to the shoulder within the last 3 months on the arm being assessed that has not resolved
  • Recent surgery to the thorax or upper limb in the last 6 months
  • Previous history of fracture to the shoulder joint being assessed
  • Co-existing neurological pathologies or additional musculoskeletal injuries to the upper limb being assessed
  • Age Matched Controls
  • \- People aged 18 years and older
  • Any previous presentation to a health care professional with a diagnosis of shoulder instability
  • Previous shoulder injury within the last 3 months on the arm being assessed that has not resolved
  • Any co-existing neurological pathologies or deficits
  • Any previous surgical intervention on the arm being assessed
  • Currently undergoing or awaiting medical management, diagnostic investigations or rehabilitation on the arm being assessed

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Robert Jones & Agnes Hunt Orthopaedic Hospital

Oswestry, Gobowen, SY10 7AG, United Kingdom

Location

MeSH Terms

Conditions

Shoulder PainNeuromuscular DiseasesShoulder InjuriesMuscular Dystrophy, Facioscapulohumeral

Interventions

High-Energy Shock Waves

Condition Hierarchy (Ancestors)

ArthralgiaJoint DiseasesMusculoskeletal DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsNervous System DiseasesWounds and InjuriesMuscular DystrophiesMuscular Disorders, AtrophicMuscular DiseasesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Intervention Hierarchy (Ancestors)

Ultrasonic WavesSoundRadiation, NonionizingRadiationPhysical Phenomena

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 27, 2022

First Posted

February 15, 2022

Study Start

March 25, 2022

Primary Completion

October 21, 2022

Study Completion

October 21, 2022

Last Updated

February 1, 2023

Record last verified: 2023-01

Data Sharing

IPD Sharing
Will share

The anonymised final trial dataset and anonymised 3D movement data files will be stored on the University of Liverpool data repository. The anonymised dataset associated with the University of Liverpool data repository will be assigned a Digital object identifier and will be openly available.

Shared Documents
STUDY PROTOCOL
More information

Locations